Endogenous tPA can be produced by microglia, neurons, and endothelial cells and is rapidly released in cerebral ischemia [19], [20] whereas recombinant tPA (rtPA) is commonly used as a thrombolytic agent to lyse blood clots. This evidence concerns the gene PLAT and brain ischemia.